BG has received fees for the activities of speaking, scientific advising, or clinical research from Eli Lilly, Novo Nordisk, AstraZeneca, Sanofi, Bristol Myers Squibb, Novartis, GlaxoSmithKline, Johnson & Johnson, Bayer, Intercept Pharma France, Gilead, Boehringer Ingelheim, Janssen, Intarcia, MetaCure, Pfizer, Merck Sharp & Dohme, Roche Diagnostics, Medtronic, Insulet, A
The kind that disrupts digestion , kills productivity, and makes researchers dread their injection day
Sandoz, a global leader in generics, in partnership with Pharmathen, a Greek pharmaceutical company, will launch its biosimilar semaglutide which will help reduce costs for patients paying high prices for branded GLP-1 drugs like Ozempic and Wegovy
Huadong Medicine, which follows closely behind, is also eyeing the opportunity
Treatment may involve cancer-directed therapy, glucocorticoid use